Moghisuddin Ahmad

Title: Innovator in Mental Health: Moghisuddin Ahmad

Introduction

Moghisuddin Ahmad, a dedicated inventor based in Wadsworth, IL, has made significant strides in the field of psychiatric treatment. His innovation revolves around a patented method designed to effectively treat bipolar I disorder, showcasing the potential for new therapeutic interventions in mental health.

Latest Patents

Moghisuddin Ahmad holds one patent for a method involving endoxifen, aimed at treating patients with bipolar I disorder. The patented method provides a streamlined approach, administering a dose of 2 mg to 16 mg of endoxifen citrate in an enteric-coated tablet once per day for at least 21 days. This innovative treatment method achieves a desirable in-vivo plasma profile, significantly improving the management of mania, as assessed by the Young Mania Rating Scale (YMRS) and the Montgomery-Åsberg Depression Rating Scale (MADRS) scores. Remarkably, the method ensures that therapeutic dose monitoring is unnecessary and leads to an early response time within at least 2 days, with remission occurring in no more than 4 days.

Career Highlights

Moghisuddin Ahmad is currently associated with Jina Pharmaceuticals, Inc., where he works alongside colleagues Ateeq Ahmad and Imran Ahmad. His efforts at the company are instrumental in pushing the boundaries of existing mental health treatments, focusing on innovative pharmaceutical solutions that can enhance patients' quality of life.

Collaborations

Collaboration plays a vital role in the development and refinement of novel treatments. Working closely with fellow inventors and professionals within Jina Pharmaceuticals, Ahmad has engaged in crucial discussions and research initiatives that propel the company's mission of providing effective mental health therapies.

Conclusion

Moghisuddin Ahmad stands out as a key innovator in the field of mental health, particularly with his patented method for treating bipolar I disorder using endoxifen. His work exemplifies the importance of innovation in developing new treatment pathways, marking a positive step forward in psychiatric care. As he continues to work at Jina Pharmaceuticals, his contributions are sure to inspire advancements in mental health treatments and improve outcomes for countless patients.